Ojasvin Cure Root Pvt Ltd

About Ojasvin Cure Root Pvt Ltd

CureRoot utilizes artificial intelligence and automated laboratory processes to explore Africa's plant biodiversity for the discovery of novel compounds targeting superbugs and emerging viruses. The platform combines traditional plant knowledge with advanced analytics to create a high-value drug pipeline that addresses critical global health challenges.

```xml <problem> The discovery of novel drugs to combat superbugs and emerging viruses is a slow and expensive process. Traditional methods of drug discovery often overlook the potential of plant biodiversity, particularly in regions like Africa, which holds a vast, largely unexplored reservoir of medicinal plants. </problem> <solution> CureRoot is developing a platform that leverages artificial intelligence and automated laboratory processes to accelerate the discovery of novel drug candidates from Africa's plant biodiversity. The company combines traditional plant knowledge with advanced analytics to identify and study bioactive molecules. By building a comprehensive chemical library of secondary metabolites derived from African medicinal plants, CureRoot aims to create a high-value drug pipeline focused on addressing critical global health challenges, including infectious diseases, oncology, cardiometabolic diseases, and autoimmune disorders. The platform uses computational testing to identify promising compounds, paving the way for safer and more effective treatments. </solution> <features> - AI-powered analysis of African plants to identify potential drug candidates. - Automated laboratory processes for high-throughput screening and compound isolation. - Development of a comprehensive chemical library of secondary metabolites from African medicinal plants. - Computational testing to predict the efficacy and safety of identified compounds. - Focus on therapeutic areas including infectious diseases, oncology, cardiometabolic diseases, and autoimmune disorders. </features> <target_audience> CureRoot's primary customers are pharmaceutical and biotechnology companies, as well as academic research institutions, interested in discovering and developing novel drugs from natural sources. </target_audience> ```

What does Ojasvin Cure Root Pvt Ltd do?

CureRoot utilizes artificial intelligence and automated laboratory processes to explore Africa's plant biodiversity for the discovery of novel compounds targeting superbugs and emerging viruses. The platform combines traditional plant knowledge with advanced analytics to create a high-value drug pipeline that addresses critical global health challenges.

Where is Ojasvin Cure Root Pvt Ltd located?

Ojasvin Cure Root Pvt Ltd is based in Noida, India.

Location
Noida, India
Employees
4 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Ojasvin Cure Root Pvt Ltd

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

CureRoot utilizes artificial intelligence and automated laboratory processes to explore Africa's plant biodiversity for the discovery of novel compounds targeting superbugs and emerging viruses. The platform combines traditional plant knowledge with advanced analytics to create a high-value drug pipeline that addresses critical global health challenges.

cure-root.com700+
Noida, India

Funding

No funding information available.

Team (<5)

No team information available.

Company Description

Problem

The discovery of novel drugs to combat superbugs and emerging viruses is a slow and expensive process. Traditional methods of drug discovery often overlook the potential of plant biodiversity, particularly in regions like Africa, which holds a vast, largely unexplored reservoir of medicinal plants.

Solution

CureRoot is developing a platform that leverages artificial intelligence and automated laboratory processes to accelerate the discovery of novel drug candidates from Africa's plant biodiversity. The company combines traditional plant knowledge with advanced analytics to identify and study bioactive molecules. By building a comprehensive chemical library of secondary metabolites derived from African medicinal plants, CureRoot aims to create a high-value drug pipeline focused on addressing critical global health challenges, including infectious diseases, oncology, cardiometabolic diseases, and autoimmune disorders. The platform uses computational testing to identify promising compounds, paving the way for safer and more effective treatments.

Features

AI-powered analysis of African plants to identify potential drug candidates.

Automated laboratory processes for high-throughput screening and compound isolation.

Development of a comprehensive chemical library of secondary metabolites from African medicinal plants.

Computational testing to predict the efficacy and safety of identified compounds.

Focus on therapeutic areas including infectious diseases, oncology, cardiometabolic diseases, and autoimmune disorders.

Target Audience

CureRoot's primary customers are pharmaceutical and biotechnology companies, as well as academic research institutions, interested in discovering and developing novel drugs from natural sources.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.